Tirzepatide
Price range: $279.00 through $1,949.00
This item includes the amount of weeks of injections selected that are all 2.5 mg doses.
Next-Generation Dual-Action Weight Loss for Breakthrough Results
Tirzepatide represents the next evolution in medically supervised weight loss — and it is quickly becoming one of the most sought-after therapies in the Rehydra+ Wellness portfolio for good reason. Unlike Semaglutide, which targets a single hormone receptor, Tirzepatide is a first-of-its-kind dual GIP and GLP-1 receptor agonist, meaning it simultaneously activates two distinct metabolic pathways that work together to produce weight loss results that consistently exceed what either mechanism can achieve alone. GIP, or glucose-dependent insulinotropic polypeptide, works in concert with GLP-1 to enhance insulin secretion, improve fat metabolism, and amplify the appetite-suppressing signals that help you eat less without feeling deprived. The result is a uniquely powerful metabolic effect that clinical trials — including the landmark SURMOUNT program — have demonstrated can produce average weight reductions of 20% or more of total body weight, making Tirzepatide the most effective pharmaceutical weight loss option currently available. Marketed under the brand name Zepbound for weight management and Mounjaro for type 2 diabetes, Tirzepatide is administered as a once-weekly subcutaneous injection and is available through Rehydra+’s telehealth program with full provider oversight, pharmacy-sourced quality, and personalized dosing from start to finish. For individuals who are serious about transformative, medically supported weight loss — or who have not achieved their goals with other interventions — Tirzepatide offers a compelling, science-backed pathway to results that genuinely change lives.
Why Choose This Product
The Most Powerful Weight Loss Results Available in a Once-Weekly Injection
Tirzepatide's dual-action mechanism sets it apart from every other weight loss medication on the market. By activating both GIP and GLP-1 receptors simultaneously, it produces a compounding metabolic effect that clinical trials have shown leads to substantially greater weight loss than GLP-1 therapies alone. In the SURMOUNT-1 trial, participants lost an average of up to 22.5% of their body weight over 72 weeks — numbers that were previously only associated with bariatric surgery. For individuals seeking maximum results from a non-surgical, medically supervised program, Tirzepatide is in a class of its own.
Dual Metabolic Action That Addresses Weight and Blood Sugar Simultaneously
Tirzepatide doesn't just suppress appetite — it fundamentally improves how your body processes and stores energy. By engaging both the GIP and GLP-1 pathways, Tirzepatide enhances insulin sensitivity, reduces fasting glucose levels, and promotes more efficient fat metabolism. This makes it particularly valuable for individuals managing prediabetes, insulin resistance, or metabolic syndrome alongside their weight — addressing the interconnected root causes of metabolic dysfunction rather than simply treating symptoms on the surface.
Break Through Plateaus That Diet, Exercise, and Other Medications Haven't Resolved
For many people who have genuinely committed to lifestyle changes or have already tried GLP-1 therapies like Semaglutide without reaching their goals, Tirzepatide offers a meaningful step up in therapeutic potency. Its dual-receptor mechanism engages metabolic pathways that single-agonist therapies simply don't activate, which is why many clients who plateau on other medications find renewed, significant progress when transitioning to Tirzepatide. If you've done the work and still feel stuck, this may be the breakthrough your body needs.
Reviewed and Trusted by Our Esteemed Customers
Trust is earned over time, and Rehydra + Wellness has built strong loyalty through responsive care and long-term patient relationships. Many customers continue returning even after reaching early milestones, which says a lot about the kind of support they receive along the way. Want a closer look at what that experience feels like? Explore reviews and testimonials to hear directly from the people who know the brand best.
What to Expect When Using This Product
Tirzepatide follows a gradual dose titration schedule — starting at a low weekly dose and increasing incrementally over several months — designed to let your body adapt to the medication’s effects while minimizing gastrointestinal discomfort along the way. In the first couple of weeks, most clients notice a meaningful reduction in appetite fairly quickly, often finding that their portion sizes naturally decrease and their interest in snacking between meals diminishes without requiring significant willpower. Some clients experience mild nausea, loose stools, or stomach discomfort during the early titration phase — these are the most common side effects and tend to resolve as the body adjusts, particularly when eating smaller, lower-fat meals and staying well hydrated. By the four- to eight-week mark, consistent and measurable weight loss is typically well underway, and many clients report feeling a profound shift not just in their body composition but in their energy levels, mobility, and overall relationship with food. As doses increase through the titration schedule over the following months, the pace of weight loss continues, and the cumulative results become increasingly transformative — often prompting improvements in blood pressure, cholesterol, blood sugar, joint comfort, and quality of sleep alongside the weight itself. Your Rehydra+ provider will monitor your progress at each stage, adjust your protocol as needed, and ensure that your experience is as effective, safe, and supported as possible from your very first dose through your long-term maintenance goals.
Now Offering Wellness Subscriptions for Your Health Goals
Consistency matters, especially when you are working toward long-term health changes. Rehydra + Wellness offers membership subscriptions for semaglutide and tirzepatide that help patients receive medication on a recurring schedule, with autopay and automated delivery designed to reduce interruptions and keep treatment moving. Current memberships also highlight added convenience perks, including priority during shortages and recurring monthly fulfillment.
Frequently Asked Questions
Both are once-weekly injectable GLP-1 therapies used for weight loss, but Tirzepatide adds a second mechanism — GIP receptor activation — that amplifies its metabolic effects and produces greater average weight loss in clinical trials. Semaglutide is an excellent, well-established option, while Tirzepatide is generally considered the more potent choice for individuals seeking maximum results or who have not reached their goals on Semaglutide. Your Rehydra+ provider will evaluate your health history, goals, and prior treatment experience during your telehealth consultation to help you determine which therapy is the best fit.
Most clients begin experiencing appetite suppression and early weight loss within the first two to four weeks, with more significant changes in body composition becoming apparent around the two- to three-month mark as the dose is titrated upward. Clinical trials showed the most dramatic weight loss results accumulating between months three and eighteen of consistent use, underscoring the importance of staying committed to the full protocol. Clients who pair Tirzepatide with supportive nutrition habits and regular physical activity consistently achieve the best outcomes.
The most frequently reported side effects are gastrointestinal — nausea, mild stomach discomfort, constipation, or diarrhea — particularly during dose increases. These are typically mild to moderate, temporary, and manageable with simple adjustments such as eating smaller meals, avoiding high-fat or heavily processed foods, and maintaining good hydration. Rehydra+’s titration protocol is specifically designed to minimize these effects by increasing doses gradually, and your provider will be available to advise and adjust your plan if needed.
Yes — Rehydra+ offers Tirzepatide as part of its weight loss membership program, making it a more cost-effective and streamlined long-term solution for clients committed to sustained results. Membership plans include ongoing provider access, medication, and the convenience of direct pharmacy-to-door delivery. Visit the Membership Plans section of the Rehydra+ website or speak with your provider to find the plan that best fits your goals and budget.
This is an important and honest question. Like most metabolic medications, Tirzepatide works best when used as part of a comprehensive, sustained wellness strategy. Some weight regain can occur after discontinuation, particularly if lifestyle habits are not maintained — this is a well-documented phenomenon with GLP-1 and dual-agonist therapies. Your Rehydra+ provider will work with you to develop a long-term plan that addresses both the medical and lifestyle components of your weight management, whether that means a maintenance dose, a structured transition protocol, or integration with other wellness therapies to preserve your results over time.
Recent Health & Wellness Articles
Want to stay sharp on the latest in wellness, weight loss, and telehealth? Rehydra + Wellness articles give readers an easy way to stay up to date on new health and wellness topics while learning more about treatment options and everyday habits that support better results.

How Long Does It Take to Lose Weight on Semaglutide or Tirzepatide?
Read More
How to Maximize Benefits with Rewards Points Programs
Read More
A Guide to Comprehensive Wellness Services
Read MoreLet Rehydra+ Help You Achieve Your Wellness Dreams
Whether you are exploring peptides for weight loss, shopping for telehealth weight loss products, or looking into TRT and broader wellness support, Rehydra + Wellness makes it easier to take the next step with confidence. Shop all products and find the treatment path that fits your goals, your schedule, and your life.
